Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 2001-2004, April 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohtani, M.
Right arrow Articles by Niijima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtani, M.
Right arrow Articles by Niijima, T.

Sequential Changes of Mouse Bladder Epithelium during Induction of Invasive Carcinomas by N-Butyl-N-(4-hydroxybutyl)nitrosamine1

Mikinobu Ohtani, Tadao Kakizoe2, Yasunori Nishio, Shigeaki Sato, Takashi Sugimura, Shoji Fukushima and Tadao Niijima

Urology Division [M. O., T. K., Y. N.] and Biochemistry Division [S. S., T. S.], National Cancer Center, Tokyo 104; Department of Pathology [S. F.], Nagoya City Medical School, Nagoya 467; and Department of Urology [T. N.], Faculty of Medicine, University of Tokyo, Tokyo 113, Japan

Invasive carcinoma of the bladder in humans shows aggressive growth with poor prognosis. Little is known about its preceding lesions. Sequential changes of the bladder epithelium following administration of N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN) were studied in mice. Female C3H/He mice were divided into 4 groups. Three groups were given 0.05, 0.01, and 0.005% concentrations of BHBN, respectively, in their drinking water, and the control group was given tap water. The mice were killed at regular intervals over a period of 26 weeks, and their bladder epithelium was examined histologically. Dysplasia, carcinoma in situ, and invasive carcinoma were observed sequentially in the groups treated with BHBN, and the incidences of dysplasia, carcinoma in situ, and invasive carcinoma were dependent on the dose of BHBN. The data indicate that bladder carcinoma in mice is a good model of invasive bladder carcinoma in humans, although it is not fully compatible with the human model because of the complete absence of metastases.

1 This work was supported by a Grant-in-Aid from the Ministry of Health and Welfare for a Comprehensive 10-Year Strategy for Cancer Control and also by Grants-in-Aid from the Ministry of Health and Welfare (58-5) and the Ministry of Education, Science, and Culture (58010062) of Japan.

2 To whom requests for reprints should be addressed, at the Urology Division, National Cancer Center, Tsukiji 5-1-1. Chuo-ku, Tokyo 104, Japan.

Received 8/26/85. Revised 12/ 4/85. Accepted 12/27/85.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
H. Miyamoto, Z. Yang, Y.-T. Chen, H. Ishiguro, H. Uemura, Y. Kubota, Y. Nagashima, Y.-J. Chang, Y.-C. Hu, M.-Y. Tsai, et al.
Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals
J Natl Cancer Inst, April 4, 2007; 99(7): 558 - 568.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hamed, H. LaRue, H. Hovington, J. Girard, L. Jeannotte, E. Latulippe, and Y. Fradet
Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice
Cancer Res., March 15, 2004; 64(6): 1938 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Shiina, M. Igawa, S. Urakami, K. Shigeno, T. Yoneda, M. Terashima, M. Deguchi, L. Ribeiro-Filho, and R. Dahiya
Alterations of {beta}- and {gamma}-Catenin in N-Butyl-N-(-4-hydroxybutyl)nitrosamine-induced Murine Bladder Cancer
Cancer Res., October 1, 2001; 61(19): 7101 - 7109.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. E. Marjou, A. Delouvee, J. P. Thiery, and F. Radvanyi
Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression
Carcinogenesis, December 1, 2000; 21(12): 2211 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. J. Grippo and E. P. Sandgren
Highly Invasive Transitional Cell Carcinoma of the Bladder in a Simian Virus 40 T-Antigen Transgenic Mouse Model
Am. J. Pathol., September 1, 2000; 157(3): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Elkin, I. Ariel, H.-Q. Miao, A. Nagler, M. Pines, N. de-Groot, A. Hochberg, and I. Vlodavsky
Inhibition of Bladder Carcinoma Angiogenesis, Stromal Support, and Tumor Growth by Halofuginone
Cancer Res., August 1, 1999; 59(16): 4111 - 4118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.